NAP1L5 antibody is affinity chromatography purified via peptide column.
Immunogen
NAP1L5 antibody was raised against an 18 amino acid peptide near the center of human NAP1L5. The immunogen is located within amino acids 40 - 90 of NAP1L5.
NAP1L5 antibody can be used for detection of NAP1L5 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in mouse samples, Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
NAP1L5 antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C,4 °C
Informationen zur Lagerung
NAP1L5 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
NAP1L5
(Nucleosome Assembly Protein 1-Like 5 (NAP1L5))
DRLM antikoerper, 1110020M21Rik antikoerper, nucleosome assembly protein 1 like 5 antikoerper, nucleosome assembly protein 1-like 5 antikoerper, NAP1L5 antikoerper, Nap1l5 antikoerper
Hintergrund
The nucleosome assembly protein 1-like 5 (NAP1L5) protein, also known as DRLM, was initially identified as a possible tumor suppressor gene in hepatocellular carcinoma (1). The NAP1L5 gene is located within the intron of Herc3, and unlike Herc3, is imprinted and highly expressed in regions of the adult mouse brain (2).